Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Clarient Inc. (“Clarient” or the “Company”) (NASDAQ: CLRT) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to General Electric Co. (NYSE: GE). The proposed transaction offers Clarient shareholders to only receive $5.00 in cash for each Clarient’s common share and $20.00 in cash for each preferred share. According to Yahoo! Finance, at least one analyst has set a price target of $6.00 per share for Clarient’s common stock. The transaction is structured as a tender offer, which may obviate the need for a shareholder vote and it is valued at approximately $587 million.

Request more information now by clicking here: www.faruqilaw.com/clrt

Whether the Clarient’s Board of Directors breached their fiduciary duties to Clarient’s stockholders by failing to conduct an adequate and fair sales process to sell the Company prior to agreeing to this proposed transaction, whether the proposed transaction undervalues Clarient’s shares and by how much this proposed transaction undervalues the Company to the detriment of Clarient shareholders are the key focus of this investigation.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, through all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients.

If you own common stock in Clarient and wish to obtain additional information, please visit us at www.faruqilaw.com/clrt or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330.

Attorney Advertising. (C) 2010 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.

Clarient, Inc. (MM) (NASDAQ:CLRT)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Clarient, Inc. (MM).
Clarient, Inc. (MM) (NASDAQ:CLRT)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Clarient, Inc. (MM).